NL184833C - 2-gesubstitueerd aminopyrimidinederivaten en farmaceutische preparaten die ze bevatten. - Google Patents

2-gesubstitueerd aminopyrimidinederivaten en farmaceutische preparaten die ze bevatten.

Info

Publication number
NL184833C
NL184833C NLAANVRAGE8001289,A NL8001289A NL184833C NL 184833 C NL184833 C NL 184833C NL 8001289 A NL8001289 A NL 8001289A NL 184833 C NL184833 C NL 184833C
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparations
preparations containing
aminopyrimidine derivatives
substituted aminopyrimidine
substituted
Prior art date
Application number
NLAANVRAGE8001289,A
Other languages
English (en)
Other versions
NL184833B (nl
NL8001289A (nl
NL184468B (nl
Original Assignee
Produits Chimiques Societe Ano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL184833(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Produits Chimiques Societe Ano filed Critical Produits Chimiques Societe Ano
Publication of NL8001289A publication Critical patent/NL8001289A/nl
Publication of NL184468B publication Critical patent/NL184468B/nl
Publication of NL184833B publication Critical patent/NL184833B/nl
Application granted granted Critical
Publication of NL184833C publication Critical patent/NL184833C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE8001289,A 1979-03-10 1980-03-04 2-gesubstitueerd aminopyrimidinederivaten en farmaceutische preparaten die ze bevatten. NL184833C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7908494 1979-03-10
GB7914987 1979-04-30
GB7914987 1979-04-30

Publications (4)

Publication Number Publication Date
NL8001289A NL8001289A (nl) 1980-09-12
NL184468B NL184468B (nl) 1989-03-01
NL184833B NL184833B (nl) 1989-06-16
NL184833C true NL184833C (nl) 1989-11-16

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8001289,A NL184833C (nl) 1979-03-10 1980-03-04 2-gesubstitueerd aminopyrimidinederivaten en farmaceutische preparaten die ze bevatten.

Country Status (24)

Country Link
JP (1) JPS55122768A (nl)
AR (1) AR222691A1 (nl)
AU (1) AU533547B2 (nl)
BE (1) BE881752A (nl)
CA (1) CA1132561A (nl)
CH (1) CH644368A5 (nl)
DE (3) DE3050999C2 (nl)
EG (1) EG14282A (nl)
FI (1) FI66357C (nl)
FR (2) FR2451370A1 (nl)
GB (1) GB2045756B (nl)
HK (1) HK55383A (nl)
IE (1) IE49547B1 (nl)
IN (1) IN153791B (nl)
LU (1) LU82185A1 (nl)
MX (1) MX6218E (nl)
MY (1) MY8400200A (nl)
NL (1) NL184833C (nl)
NO (1) NO154054C (nl)
NZ (1) NZ192927A (nl)
OA (1) OA06484A (nl)
PT (1) PT70882A (nl)
SE (1) SE435180B (nl)
SG (1) SG22683G (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
FI66357B (fi) 1984-06-29
NL184833B (nl) 1989-06-16
IN153791B (nl) 1984-08-18
LU82185A1 (fr) 1980-06-06
FI66357C (fi) 1984-10-10
DE3050999A1 (nl) 1985-08-14
OA06484A (fr) 1981-07-31
NO800664L (no) 1980-09-11
JPS55122768A (en) 1980-09-20
DE3009071C2 (de) 1985-11-14
NO154054C (no) 1986-07-09
CH644368A5 (en) 1984-07-31
NL8001289A (nl) 1980-09-12
JPS6126996B2 (nl) 1986-06-23
MX6218E (es) 1984-12-21
AU533547B2 (en) 1983-12-01
GB2045756B (en) 1983-01-26
DE3009071A1 (de) 1980-09-11
EG14282A (en) 1983-09-30
SE8001812L (sv) 1980-09-11
AU5624880A (en) 1980-09-18
GB2045756A (en) 1980-11-05
NO154054B (no) 1986-04-01
MY8400200A (en) 1984-12-31
PT70882A (en) 1980-03-01
SG22683G (en) 1983-12-16
IE49547B1 (en) 1985-10-30
FR2451191B1 (nl) 1983-04-29
NL184468B (nl) 1989-03-01
IE800477L (en) 1980-09-10
FI800566A (fi) 1980-09-11
NZ192927A (en) 1981-07-13
AR222691A1 (es) 1981-06-15
DE3016752C2 (nl) 1987-06-25
DE3016752A1 (de) 1980-12-04
FR2451370B1 (nl) 1983-05-13
SE435180B (sv) 1984-09-10
CA1132561A (en) 1982-09-28
FR2451370A1 (fr) 1980-10-10
FR2451191A1 (fr) 1980-10-10
DE3050999C2 (de) 1986-08-14
BE881752A (fr) 1980-05-30
HK55383A (en) 1983-11-25

Similar Documents

Publication Publication Date Title
NL190552C (nl) 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL930106I2 (nl) Ergolineverbindingen, hun bereiding en farmaceutische preparaten die ze bevatten.
NO801863L (no) Farmasoeytiske preparater.
NL960028I2 (nl) ML-236B-derivaten, werkwijze voor hun bereiding enfarmaceutische preparaten, die deze derivaten bevatten.
NL970028I1 (nl) 2(1H)-Pyridinonderivaten en farmaceutische preparaten die deze derivaten bevatten.
NL182775C (nl) Corticosteroide bevattende farmaceutische preparaten.
NL192721B (nl) Benzonorborneenderivaten, werkwijzen voor het bereiden ervan alsmede geneeskundige en cosmetische preparaten, die dergelijke derivaten bevatten.
NL7811692A (nl) Fenylglycine-derivaten en preparaten die ze bevatten.
NL7810865A (nl) 6,7-dialkoxy-4-piperidinochinazolinen, farmaceutische preparaten die ze bevatten, en werkwijzen voor de be- reiding daarvan.
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
NL184833C (nl) 2-gesubstitueerd aminopyrimidinederivaten en farmaceutische preparaten die ze bevatten.
NL7803162A (nl) Nieuwe 1-aminoindaanderivaten, alsmede farmaceutische preparaten die deze bevatten.
NL184467C (nl) 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten.
NL190520B (nl) Op plaats 1 gesubstitueerde, 7-gesubstitueerde amino-6-halogeen-4-oxo-1,4-dihydrochinoline-3-carbonzuren en farmaceutische preparaten, die deze bevatten.
NL930126I2 (nl) Dihydropyridine derivaten, werkwijze voor hun bereiding en farmaceutische preparaten die ze bevatten.
NL7703898A (nl) Werkwijze voor het bereiden van 2-gesubstitueer- de trans-hexahydropyridoindolen, werkwijze voor het bereiden van farmaceutische preparaten met toepassing daarvan alsmede zo gevormde prepara- ten.
NL191307C (nl) Analgetisch werkzame piperazinederivaten en farmaceutische preparaten, die deze derivaten bevatten.
NL188645B (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL7704542A (nl) Werkwijze voor het bereiden van isothiazolopyri- dinederivaten, alsmede farmaceutische preparaten die deze verbinding bevatten.
NL187397C (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
NL7811292A (nl) Pyridoxol-derivaat, werkwijze voor de bereiding daarvan en farmaceutische preparaten die het bevatten.
NL7803448A (nl) Nieuwe benzothiadiazinederivaten, alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL7802826A (nl) Thienamycinederivaat, werkwijze voor het bereiden daarvan, alsmede farmaceutische preparaten.
NL7902993A (nl) Nieuwe isochinolinederivaten, de bereiding ervan en farmaceutische preparaten, die de nieuwe isochinoline- derivaten bevatten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed
V1 Lapsed because of non-payment of the annual fee